应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02616 基石药业-B
已收盘 12-05 16:09:08
5.670
-0.100
-1.73%
最高
5.840
最低
5.530
成交量
587.95万
今开
5.770
昨收
5.770
日振幅
5.37%
总市值
83.69亿
流通市值
83.69亿
总股本
14.76亿
成交额
3,334万
换手率
0.40%
流通股本
14.76亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
基石药业(02616)发布2025年11月月报,股本维持稳定
公告速递 · 12-04 16:59
基石药业(02616)发布2025年11月月报,股本维持稳定
每日卖空追踪 | 基石药业-B 12月04日卖空量成交68.5万股,卖空比例为11.07%
市场透视 · 12-04 16:30
每日卖空追踪 | 基石药业-B 12月04日卖空量成交68.5万股,卖空比例为11.07%
基石药业-B12月03日主力净流出248.5万元 散户资金买入
市场透视 · 12-03 16:15
基石药业-B12月03日主力净流出248.5万元 散户资金买入
每日卖空追踪 | 基石药业-B 12月01日卖空量成交37万股,卖空比例为4.09%
市场透视 · 12-01
每日卖空追踪 | 基石药业-B 12月01日卖空量成交37万股,卖空比例为4.09%
基石药业-B12月01日主力净流出429.6万元 散户资金买入
市场透视 · 12-01
基石药业-B12月01日主力净流出429.6万元 散户资金买入
港股异动 | 基石药业-B(02616)现涨超5% 欧盟委员会批准舒格利单抗用于治疗III期非小细胞肺癌
智通财经 · 11-27
港股异动 | 基石药业-B(02616)现涨超5% 欧盟委员会批准舒格利单抗用于治疗III期非小细胞肺癌
舒格利单抗再传捷报!Ⅲ期非小细胞肺癌适应症在欧洲正式获批
药学进展 · 11-26
舒格利单抗再传捷报!Ⅲ期非小细胞肺癌适应症在欧洲正式获批
每日卖空追踪 | 基石药业-B 11月26日卖空量成交113.25万股,卖空比例为9.02%
市场透视 · 11-26
每日卖空追踪 | 基石药业-B 11月26日卖空量成交113.25万股,卖空比例为9.02%
港股基石药业-B涨超5%
每日经济新闻 · 11-26
港股基石药业-B涨超5%
港股异动 | 基石药业-B(02616)涨超5% 欧盟委员会已批准舒格利单抗的新适应症
智通财经 · 11-26
港股异动 | 基石药业-B(02616)涨超5% 欧盟委员会已批准舒格利单抗的新适应症
基石药业-B(02616):舒格利单抗获欧盟委员会批准用于治疗Ⅲ期非小细胞肺癌
智通财经 · 11-25
基石药业-B(02616):舒格利单抗获欧盟委员会批准用于治疗Ⅲ期非小细胞肺癌
基石药业-B - 欧盟委员会批准Sugmalimab用于III期非小细胞肺癌
美股速递 · 11-25
基石药业-B - 欧盟委员会批准Sugmalimab用于III期非小细胞肺癌
ORR 100%!国产三抗临床数据密集读出,TCE、NKCE、免疫检查点靶向三抗引领差异化竞争
医麦客 · 11-21
ORR 100%!国产三抗临床数据密集读出,TCE、NKCE、免疫检查点靶向三抗引领差异化竞争
每日卖空追踪 | 基石药业-B 11月20日卖空量成交153.1万股,卖空比例为13.38%
市场透视 · 11-20
每日卖空追踪 | 基石药业-B 11月20日卖空量成交153.1万股,卖空比例为13.38%
基石药业-B11月20日获主力加仓34.8万元
市场透视 · 11-20
基石药业-B11月20日获主力加仓34.8万元
Yang Jianxin增持基石药业-B(02616)4万股 每股作价6.14港元
智通财经 · 11-18
Yang Jianxin增持基石药业-B(02616)4万股 每股作价6.14港元
每日卖空追踪 | 基石药业-B 11月18日卖空量成交26.1万股,卖空比例为4.87%
市场透视 · 11-18
每日卖空追踪 | 基石药业-B 11月18日卖空量成交26.1万股,卖空比例为4.87%
执行董事杨建新增持基石药业(02616)11.75万股 每股均价约5.42港元
智通财经网 · 11-14
执行董事杨建新增持基石药业(02616)11.75万股 每股均价约5.42港元
港股生物医药股持续走强!旺山旺水-B涨近30%,圣诺医药-B涨超18%
老虎资讯综合 · 11-14
港股生物医药股持续走强!旺山旺水-B涨近30%,圣诺医药-B涨超18%
基石药业-B(02616.HK)早盘涨超9%
每日经济新闻 · 11-14
基石药业-B(02616.HK)早盘涨超9%
加载更多
公司概况
公司名称:
基石药业-B
所属市场:
SEHK
上市日期:
--
主营业务:
基石药业是一家主要专注于抗肿瘤药物研发的生物制药投资控股公司。该公司通过子公司主要从事生物制药产品的研发、销售药品及提供其知识产权授权或商业化授权。该公司主要产品包括精准治疗药物泰吉华(阿伐替尼)及普吉华(普拉替尼)。该公司还从事肿瘤免疫药物的开发及商业化。该公司主要在中国国内和海外市场开展业务,如中欧及东欧和瑞士。
发行价格:
--
{"stockData":{"symbol":"02616","market":"HK","secType":"STK","nameCN":"基石药业-B","latestPrice":5.67,"timestamp":1764922148004,"preClose":5.77,"halted":0,"volume":5879500,"delay":0,"floatShares":1476000000,"shares":1476000000,"eps":-0.07869855123983029,"marketStatus":"已收盘","change":-0.1,"latestTime":"12-05 16:09:08","open":5.77,"high":5.84,"low":5.53,"amount":33340415,"amplitude":0.053726,"askPrice":5.67,"askSize":12000,"bidPrice":5.65,"bidSize":30000,"shortable":3,"etf":0,"ttmEps":-0.32134957282883725,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"listingDate":1551110400000,"exchange":"SEHK","adjPreClose":5.77,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.8189,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02616","defaultTab":"news","newsList":[{"id":"1171138252","title":"基石药业(02616)发布2025年11月月报,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1171138252","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171138252?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:59","pubTimestamp":1764838777,"startTime":"0","endTime":"0","summary":"基石药业于2025年12月4日公布截至2025年11月30日的股份变动月报。报告显示,公司法定注册股本维持2,000,000,000股,面值0.0001美元,注册股本总额200,000美元,与上月无异动。已发行股本方面,截至2025年11月底,公司已发行股份数为1,475,977,923股,较上月保持不变。首次公开发售后员工持股计划中,有7,500份期权于本月内失效,对公司已发行股份总数无实质影响。公司表示,将继续遵守香港联合交易所有限公司上市规则及相关法律。公告由董事李伟签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616"],"gpt_icon":0},{"id":"2588887931","title":"每日卖空追踪 | 基石药业-B 12月04日卖空量成交68.5万股,卖空比例为11.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588887931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588887931?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837033,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间12月04日,涨2.85%,卖空量成交68.5万股,较上一交易日减少64.2%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163505a4cc380b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163505a4cc380b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02616","BK1574","BK1161"],"gpt_icon":0},{"id":"2588166730","title":"基石药业-B12月03日主力净流出248.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588166730","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588166730?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:15","pubTimestamp":1764749747,"startTime":"0","endTime":"0","summary":"12月03日, 基石药业-B股价跌1.92%,报收5.61元,成交金额3087.1万元,换手率0.37%,振幅4.72%,量比0.59。基石药业-B今日主力资金净流出248.5万元,上一交易日主力净流入158.9万元。该股近5个交易日下跌5.05%,主力资金累计净流出232.2万元;近20日主力资金累计净流出3435.9万元,其中净流出天数为10日。该股主力净额占比0.03%,港股市场排名2510/2682。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203161954a4c9e5f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203161954a4c9e5f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02616","BK1161"],"gpt_icon":0},{"id":"2588974776","title":"每日卖空追踪 | 基石药业-B 12月01日卖空量成交37万股,卖空比例为4.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588974776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588974776?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577832,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间12月01日,跌6.22%,卖空量成交37万股,较上一交易日减少70.82%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163446a4c551ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163446a4c551ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2588177699","title":"基石药业-B12月01日主力净流出429.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588177699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588177699?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576933,"startTime":"0","endTime":"0","summary":"12月01日, 基石药业-B股价跌6.22%,报收5.73元,成交金额5190.9万元,换手率0.61%,振幅9.17%,量比1.05。基石药业-B今日主力资金净流出429.6万元,上一交易日主力净流入9.1万元。该股近5个交易日上涨1.96%,主力资金累计净流出1157.4万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出3413.8万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116173397894b75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116173397894b75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02616","BK1161"],"gpt_icon":0},{"id":"2586970219","title":"港股异动 | 基石药业-B(02616)现涨超5% 欧盟委员会批准舒格利单抗用于治疗III期非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2586970219","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586970219?lang=zh_cn&edition=full","pubTime":"2025-11-27 13:43","pubTimestamp":1764222201,"startTime":"0","endTime":"0","summary":"消息面上,基石药业宣布,欧盟委员会已批准舒格利单抗的新适应症:单药治疗肿瘤细胞PD-L1表达≥1%、无EGFR敏感突变或ALK、ROS1基因组变异、在含铂放化疗后未出现疾病进展的、不可切除的III期非小细胞肺癌成人患者。基石药业将继续推进舒格利单抗在全球的可及性,践行对患者的长期承诺。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374355.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","BK4134","III","02616"],"gpt_icon":0},{"id":"2586250477","title":"舒格利单抗再传捷报!Ⅲ期非小细胞肺癌适应症在欧洲正式获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2586250477","media":"药学进展","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586250477?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:01","pubTimestamp":1764147691,"startTime":"0","endTime":"0","summary":"中国苏州,2025年11月25日——基石药业,一家专注于肿瘤、自身免疫与炎症等关键疾病领域药物研发的创新驱动型生物医药企业,今日宣布欧盟委员会已批准舒格利单抗的新适应症:单药用于治疗肿瘤细胞PD-L1表达≥1%、无表皮生长因子受体敏感突变或ALK、ROS1基因组变异、在含铂放化疗后未出现疾病进展的、不可切除的Ⅲ期非小细胞肺癌成人患者。截至目前,公司已成功上市4款创新药、获批16项新药上市申请以及9项适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126194136a712e6a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126194136a712e6a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2586504702","title":"每日卖空追踪 | 基石药业-B 11月26日卖空量成交113.25万股,卖空比例为9.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586504702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586504702?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:30","pubTimestamp":1764145828,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间11月26日,涨5.32%,卖空量成交113.25万股,较上一交易日增加61.55%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126163446951b4bc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126163446951b4bc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02616"],"gpt_icon":0},{"id":"2586289799","title":"港股基石药业-B涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586289799","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586289799?lang=zh_cn&edition=full","pubTime":"2025-11-26 10:17","pubTimestamp":1764123476,"startTime":"0","endTime":"0","summary":"每经AI快讯,基石药业-B(02616.HK)涨超5%,截至发稿,涨5.32%,报5.94港元,成交额822.94万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511263575192480.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511263575192480.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02616","BK1574"],"gpt_icon":0},{"id":"2586095286","title":"港股异动 | 基石药业-B(02616)涨超5% 欧盟委员会已批准舒格利单抗的新适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2586095286","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586095286?lang=zh_cn&edition=full","pubTime":"2025-11-26 09:58","pubTimestamp":1764122332,"startTime":"0","endTime":"0","summary":"消息面上,11月25日,基石药业公布,欧盟委员会已批准舒格利单抗的新适应症:单药治疗肿瘤细胞PD-L1 表达≥1%、无EGFR敏感突变或ALK、ROS1基因组变异、在含铂放化疗后未出现疾病进展的、不可切除的III期非小细胞肺癌成人患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 基石药业-B(02616)涨超5% 欧盟委员会已批准舒格利单抗的新适应症","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02616","BK1574"],"gpt_icon":0},{"id":"2586445523","title":"基石药业-B(02616):舒格利单抗获欧盟委员会批准用于治疗Ⅲ期非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2586445523","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586445523?lang=zh_cn&edition=full","pubTime":"2025-11-25 12:10","pubTimestamp":1764043854,"startTime":"0","endTime":"0","summary":"智通财经APP讯,基石药业-B 公布,欧盟委员会已批准舒格利单抗的新适应症:单药治疗肿瘤细胞PD-L1 表达≥1%、无EGFR敏感突变或ALK、ROS1基因组变异、在含铂放化疗后未出现疾病进展的、不可切除的III期非小细胞肺癌成人患者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373158.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"基石药业-B(02616):舒格利单抗获欧盟委员会批准用于治疗Ⅲ期非小细胞肺癌","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02616","BK1161","BK1574"],"gpt_icon":0},{"id":"1162050248","title":"基石药业-B - 欧盟委员会批准Sugmalimab用于III期非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1162050248","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162050248?lang=zh_cn&edition=full","pubTime":"2025-11-25 12:06","pubTimestamp":1764043577,"startTime":"0","endTime":"0","summary":"基石药业-B - 欧盟委员会批准Sugmalimab用于III期非小细胞肺癌","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02616","BK1574"],"gpt_icon":0},{"id":"2585519970","title":"ORR 100%!国产三抗临床数据密集读出,TCE、NKCE、免疫检查点靶向三抗引领差异化竞争","url":"https://stock-news.laohu8.com/highlight/detail?id=2585519970","media":"医麦客","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585519970?lang=zh_cn&edition=full","pubTime":"2025-11-21 07:21","pubTimestamp":1763680869,"startTime":"0","endTime":"0","summary":"根据披露,信达生物、齐鲁制药将首次公布其三抗初步临床数据,天广实生物也将更新其三抗的最新进展。(推荐阅读1:ORR 最高达 100%!信达生物三抗 IBI3003 首披临床数据;推荐阅读2:齐鲁制药 GPRC5D/BCMA/CD3 三抗首个人体临床试验结果公布)除 ASH 年会外,近期多项三抗研究数据同样引人注目。该药物拟被用于治疗自身免疫性疾病。目前,三特异性抗体可根据其作用机制分为T 细胞接合器、NK 细胞接合器和靶向免疫检查点等多种类型。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121073405a707910d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121073405a707910d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02616","BK1574","02096"],"gpt_icon":0},{"id":"2584384921","title":"每日卖空追踪 | 基石药业-B 11月20日卖空量成交153.1万股,卖空比例为13.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584384921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584384921?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:30","pubTimestamp":1763627431,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间11月20日,涨6.6%,卖空量成交153.1万股,较上一交易日增加73.29%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120163623a70647d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120163623a70647d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02616","BK1574","BK1161"],"gpt_icon":0},{"id":"2584138421","title":"基石药业-B11月20日获主力加仓34.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584138421","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584138421?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:15","pubTimestamp":1763626544,"startTime":"0","endTime":"0","summary":"11月20日, 基石药业-B股价涨6.60%,报收5.98元,成交金额6745.6万元,换手率0.78%,振幅7.31%,量比1.19。基石药业-B今日主力资金净流入34.8万元,连续3日净流入,上一交易日主力净流入207.8万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为44.44%,平均涨幅为6.50%。该股近5个交易日上涨9.65%,主力资金累计净流入381.0万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流出3281.0万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112016195895103373&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112016195895103373&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02616"],"gpt_icon":0},{"id":"2584397009","title":"Yang Jianxin增持基石药业-B(02616)4万股 每股作价6.14港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584397009","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584397009?lang=zh_cn&edition=full","pubTime":"2025-11-18 19:16","pubTimestamp":1763464569,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,11月14日,Yang Jianxin增持基石药业-B(02616)4万股,每股作价6.14港元,总金额为24.56万港元。增持后最新持股数目约为7149.02万股,持股比例为4.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02616","BK1574"],"gpt_icon":0},{"id":"2584932486","title":"每日卖空追踪 | 基石药业-B 11月18日卖空量成交26.1万股,卖空比例为4.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584932486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584932486?lang=zh_cn&edition=full","pubTime":"2025-11-18 16:30","pubTimestamp":1763454630,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间11月18日,跌2.09%,卖空量成交26.1万股,较上一交易日减少43.08%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118163453950bc517&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118163453950bc517&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02616","BK1161","BK1574"],"gpt_icon":0},{"id":"2583570157","title":"执行董事杨建新增持基石药业(02616)11.75万股 每股均价约5.42港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583570157","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583570157?lang=zh_cn&edition=full","pubTime":"2025-11-14 18:52","pubTimestamp":1763117574,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示,11月13日,执行董事杨建新增持基石药业(02616)11.75万股,每股均价5.4183港元,总金额约为63.67万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20251114/20251114185330_60112.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251114/20251114185330_60112.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","02616","BK1161"],"gpt_icon":0},{"id":"1143322445","title":"港股生物医药股持续走强!旺山旺水-B涨近30%,圣诺医药-B涨超18%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143322445","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143322445?lang=zh_cn&edition=full","pubTime":"2025-11-14 11:20","pubTimestamp":1763090400,"startTime":"0","endTime":"0","summary":"11月14日,港股$生物(000504)$医药股盘中逆势拉升,$基石药业-B(02616)$涨超11%,$歌礼制药-B(01672)$涨超9%,$圣诺医药-B(02257)$、$来凯医药-B(02105)$涨近7%,$派格生物医药-B(02565)$、$永泰生物-B(06978)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5d27790606b64b3231c65f4df87c0e89","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","02257","02616","01672"],"gpt_icon":0},{"id":"2583547106","title":"基石药业-B(02616.HK)早盘涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583547106","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583547106?lang=zh_cn&edition=full","pubTime":"2025-11-14 10:21","pubTimestamp":1763086876,"startTime":"0","endTime":"0","summary":"每经AI快讯,基石药业-B(02616.HK)早盘涨超9%,截至发稿,涨8.93%,报5.98港元,成交额2068.95万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511143564583618.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511143564583618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02616","BK1574","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cstonepharma.com","stockEarnings":[{"period":"1week","weight":-0.0768},{"period":"1month","weight":-0.0479},{"period":"3month","weight":-0.532},{"period":"6month","weight":0.4757},{"period":"1year","weight":1.6227},{"period":"ytd","weight":1.5087}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.0204},{"period":"6month","weight":0.0901},{"period":"1year","weight":0.3137},{"period":"ytd","weight":0.2929}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"基石药业是一家主要专注于抗肿瘤药物研发的生物制药投资控股公司。该公司通过子公司主要从事生物制药产品的研发、销售药品及提供其知识产权授权或商业化授权。该公司主要产品包括精准治疗药物泰吉华(阿伐替尼)及普吉华(普拉替尼)。该公司还从事肿瘤免疫药物的开发及商业化。该公司主要在中国国内和海外市场开展业务,如中欧及东欧和瑞士。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.062298},{"month":2,"riseRate":0.333333,"avgChangeRate":0.039956},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.10478},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.048094},{"month":5,"riseRate":0.5,"avgChangeRate":0.100514},{"month":6,"riseRate":0.714286,"avgChangeRate":0.09443},{"month":7,"riseRate":0.571429,"avgChangeRate":0.05639},{"month":8,"riseRate":0.428571,"avgChangeRate":0.079119},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.071005},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.012196},{"month":11,"riseRate":0.571429,"avgChangeRate":0.010396},{"month":12,"riseRate":0.428571,"avgChangeRate":0.016214}],"exchange":"SEHK","name":"基石药业-B","nameEN":"CSTONE PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"基石药业-B(02616)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供基石药业-B(02616)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"基石药业-B,02616,基石药业-B股票,基石药业-B股票老虎,基石药业-B股票老虎国际,基石药业-B行情,基石药业-B股票行情,基石药业-B股价,基石药业-B股市,基石药业-B股票价格,基石药业-B股票交易,基石药业-B股票购买,基石药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"基石药业-B(02616)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供基石药业-B(02616)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}